Fig. 3
From: Methylation patterns in serum DNA for early identification of disseminated breast cancer
EFC#93 serum DNAme and CTC analyses in the SUCCESS trial in samples taken before chemotherapy. KaplanāMeier analysis for relapse-free survival (a) and overall survival (b) according to the presence (EFC#93 pattern frequencyāā„ā0.00008) or absence (EFC#93 pattern frequencyā<ā0.00008) of marker EFC#93 before chemotherapy. KaplanāMeier analysis for relapse-free survival (c) and overall survival (d) according to the presence/absence of EFC#93 and CTCs. P values from a two-sided log-rank test. CTCā no CTC present, CTC+ at least one CTC present